pharma · Aplastic Anemia · Advanced Hepatocellular Carcinoma
Kyowa Kirin International
KYOWA KIRIN AUSTRALIA PTY LTD
Kyowa Kirin International clinical programs — 5 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- GB
- Founded
- 1995
- Employees
- 690
- Programs
- 15
- Drugs
- 12
- Patents
- 0
Kyowa Kirin International projects
5 ClinicalTrials.gov programs sponsored by Kyowa Kirin International.
Kyowa Kirin International has 5 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
2223-001
KYOWA KIRIN AUSTRALIA PTY LTD
T-cell Non-Hodgkin Lymphoma, Cutaneous T-cell lymphoma (CTCL), Peripheral T-cell lymphoma (PTCL)
1 trial -
ARQ 197
KYOWA KIRIN AUSTRALIA PTY LTD
Advanced Hepatocellular Carcinoma
1 trial -
KHK6640
KYOWA KIRIN AUSTRALIA PTY LTD
Alzheimer Disease
1 trial -
KK8123
KYOWA KIRIN AUSTRALIA PTY LTD
X-linked hypophosphatemia.
1 trial -
Placebo
KYOWA KIRIN AUSTRALIA PTY LTD
Healthy Volunteers Essential Hypertension
1 trial
Frequently asked questions
How many clinical projects does Kyowa Kirin International have?
5 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.